Thomas Schmidt
Fortune : 258 300 $ au 31/05/2026
Fortune : 258 300 $ au 31/05/2026
Thomas Schmidt currently works at Evaxion AS, as Chief Financial Officer from 2024.
Mr. Schmidt also formerly worked at Ambu A, as Chief Financial Officer from 2022 to 2023 and Roche Pharma AG, as Chief Financial Officer from 2016 to 2020.
Mr. Schmidt received his graduate degree from Copenhagen Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVAXION A/S 0,15% | 18/03/2026 | 645 750 ( 0,15% ) | 258 300 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EVAXION A/S | Directeur Financier/CFO | 01/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| AMBU A/S | Directeur Financier/CFO | 31/12/2023 |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Engages in marketing and distributing prescription medications | Directeur Financier/CFO | 01/11/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Ambu A/S
Ambu A/S Medical SpecialtiesHealth Technology Manufactures and markets diagnostic and life supporting devices for hospitals | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Engages in marketing and distributing prescription medications | Distribution Services |
Evaxion Biotech A/S
Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national